For the second time in a row, first Dr. Elizabeth Blackburn in 2010, and Dr. Shinya Yamanaka in 2012, a featured speaker of the Cell Press-TNQ India Distinguished Lectureship Series wins the Nobel Prize for Medicine. Congratulations Prof. Yamanaka, from all of us at TNQ. It was a great moment when you visited us earlier this year. And it is a proud moment now.
Shinya Yamanaka, the Japanese physician and celebrated adult stem cell researcher, delivered the Third Edition of The Cell Press-TNQ India Distinguished Lectureship Series in Bengaluru, Chennai, and New Delhi in January-February 2012. His Lecture is titled “New Era of Medicine with iPS Cells”. The schedule of the Lectures is given below.
Professor Yamanaka’s scientific breakthrough was the creation of embryonic-like stem cells from adult skin cells. Robert Lanza, Chief Scientific Officer of Advanced Cell Technology and Adjunct Professor at the Institute for Regenerative Medicine at Wake Forest University, has said that Yamanaka's work "is likely to be the most important stem-cell breakthrough of all time. The ability to generate an unlimited supply of patient-specific stem cells will revolutionize the future of medicine."
Professor Yamanaka divides his time between Kyoto and San Francisco. He serves as the Director of the Center for iPS Cell Research and Application and as Professor at the Institute for Frontier Medical Sciences at Kyoto University. He is also a Senior Investigator at the UCSF-affiliated J. David Gladstone Institutes and a Professor of Anatomy at the University of California, San Francisco (UCSF).
Shinya Yamanaka's career in science has been a distinguished one. He was awarded the Albert Lasker Prize in 2009 and The Wolf Prize in 2011. These cap a long list of awards that are detailed below.
The stated goal of Professor Yamanaka's laboratory has been to generate pluripotent stem cells from human somatic cells.
The ability to "reprogram" adult cells back into an earlier, undifferentiated state has helped to reshape the ethical debate over stem-cell research by providing an approach for obtaining pluripotent stem cells that does not require that they be taken from an embryo.
Earlier observations that somatic cells could be reprogrammed either by nuclear transfer into oocytes or by fusion with embryonic stem (ES) cells suggested that oocytes and ES cells contain factors that induce reprogramming. By identifying these factors, Yamanaka reasoned that it should be possible to induce pluripotency in somatic cells without using embryos or oocytes.
The significance of this is that ES cells, derived from the inner cell mass of mammalian blastocysts, can grow indefinitely while maintaining pluripotency. These properties have led to expectations that ES cells might be useful to treat a host of degenerative diseases, such as Parkinson's and Diabetes, as well as injuries including spinal cord injury. However, clinical application of human ES cells raises issues about the ethical use of human embryos and problems with tissue rejection after implantation. By generating pluripotent cells directly from somatic cells, it may be possible to circumvent these issues. Once established, these cells may be used in regenerative medicine and also to elucidate disease mechanisms and to screen drugs.
Venki Ramakrishnan is the recipient of the 2009 Nobel Prize in Chemistry and currently the 62nd President of The Royal Society. He is also a member of the European Molecular Biology Organization (EMBO), and a member of the U.S. National Academy of Sciences.Heis also the author of Gene Machine, a popular book on the quest for the structure of the ribosome.
Dr Helen H. Hobbs is a physician-scientist who attended Stanford University and Case Western Reserve Medical School before training in internal medicine at Columbia-Presbyterian Hospital in New York City and the University of Texas Southwestern Medical Center in Dallas, TX. After completing a post-doctoral fellowship in the laboratory of Drs. Joseph Goldstein and Michael Brown, she joined the faculty of UT Southwestern.
Dr Anderson is the Seymour Benzer Professor of Biology, Tianqiao and Chrissy Chen Leadership Chair, and Director of the Tianqiao and Chrissy Chen Institute for Neuroscience at the California Institute of Technology - Caltech in Pasadena. He is also an Investigator of the Howard Hughes Medical Institute.
The seventh speaker was Professor Mary-Claire King, an American human geneticist and professor at the University of Washington. She is known for her accomplishments in identifying breast cancer genes, demonstrating that humans and chimpanzees are 99% genetically identical, and applying genomic sequencing to identify victims of human rights abuses.
Deisseroth pioneered a groundbreaking technique known as optogenetics -- in which neurons in the brain are genetically engineered to express a light-sensitive protein that can change their electric properties.
Dr. Lander is also Professor of Biology at MIT and Professor of Systems Biology at the Harvard Medical School. Dr. Lander additionally serves as Co-Chair of the US President’s Council of Advisors on Science and Technology.
Huda Zoghbi, a physician-scientist in the field of neurogenetics and the recipient of the 2013 Pearl Meister Greengard Prize, the 2013 Dickson Prize in Medicine, and the 2011 Gruber Prize in Neuroscience was selected as the Featured Speaker of the Cell Press-TNQ India Distinguished Lectureship Series 2014.
The prize is "for the discovery of how chromosomes are protected by telomeres and the enzyme telomerase", states the official news by the Nobel Foundation. The announcement came shortly after Prof. Blackburn returned after her lecture tour of India.
He delivered the first lecture of the series on January 14 at the Teen Murti auditorium in New Delhi, did press and television interviews, met with policy makers, moved to Bangalore where he delivered two lectures...